P/FP ratio: Artificial Intelligence in Categorizing the Severity of Oxygenation by Incorporating the PEEP Into the Definition of ARDS in Ventilated Patients
Sponsor
National University Health System, Singapore (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05371314
Collaborator
(none)
5,000
1
10
502.3
Study Details
Study Description
Brief Summary
Artificial Intelligence in categorizing the severity of Oxygen in ventilated patients to predict initiation of treatment measures to improve mortality - P/FP ratio
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
5000 participants
Observational Model:
Case-Control
Time Perspective:
Retrospective
Official Title:
Artificial Intelligence in Categorizing the Severity of Oxygenation by Incorporating the PEEP Into the Definition of ARDS in Ventilated Patients
Actual Study Start Date
:
Dec 1, 2021
Anticipated Primary Completion Date
:
Jul 15, 2022
Anticipated Study Completion Date
:
Sep 30, 2022
Outcome Measures
Primary Outcome Measures
- Artificial intelligence in categorizing the severity of oxygenation of ARDS in ventilated patients [Baseline ABG done at (approximately 4 hour after intubation) to ABG done day 2,3 and day 7]
To see the trend and difference between day 1, 2,3 and day 7 between P/F (PaO2/FiO2) and S/F(SaO2/FiO2) ratio to P/FP (PaO2/FiO2*PEEP) ratio and S/FP (SpO2/(FiO2*PEEP) ratio respectively.
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Intubated patients
Exclusion Criteria:
-
pediatric and neonates
-
DNR patients
-
Non intubated patients
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | National Universty Health System | Singapore | Singapore |
Sponsors and Collaborators
- National University Health System, Singapore
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Sunitha PalaniDurai,
Principal Investigator,
National University Health System, Singapore
ClinicalTrials.gov Identifier:
NCT05371314
Other Study ID Numbers:
- NUHS
First Posted:
May 12, 2022
Last Update Posted:
May 12, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No